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Background: Health inequalities have been extensively documented, internationally and in New Zealand. The cost
of reducing health inequities is often perceived as high; however, recent international studies suggest the cost of
“doing nothing” is itself significant. This study aimed to develop a preliminary estimate of the economic cost of
health inequities between Māori (indigenous) and non-Māori children in New Zealand.
Methods: Standard quantitative epidemiological methods and “cost of illness” methodology were employed,
within a Kaupapa Māori theoretical framework. Data were obtained from national data collections held by the New
Zealand Health Information Service and other health sector agencies.
Results: Preliminary estimates suggest child health inequities between Māori and non-Māori in New Zealand are
cost-saving to the health sector. However the societal costs are significant. A conservative “base case” scenario
estimate is over $NZ62 million per year, while alternative costing methods yield larger costs of nearly $NZ200
million per annum. The total cost estimate is highly sensitive to the costing method used and Value of Statistical
Life applied, as the cost of potentially avoidable deaths of Māori children is the major contributor to this estimate.
Conclusions: This preliminary study suggests that health sector spending is skewed towards non-Māori children
despite evidence of greater Māori need. Persistent child health inequities result in significant societal economic
costs. Eliminating child health inequities, particularly in primary care access, could result in significant economic
benefits for New Zealand. However, there are conceptual, ethical and methodological challenges in estimating the
economic cost of child health inequities. Re-thinking of traditional economic frameworks and development of more
appropriate methodologies is required.Background
Health inequalities have been extensively documented,
internationally and in New Zealand [1-4]. The cost of re-
ducing health inequities (defined here as those inequal-
ities in health between population groups that are
unnecessary, preventable, and amenable to policy inter-
vention [4-6]) is often perceived as high. However, re-
cent international studies suggest the cost of “doing
nothing” is itself significant. Studies from Europe and
North America estimate the economic costs of health
inequities in adults as 2–4.4% of Gross Domestic Prod-
uct, and 15–20% of health sector expenditure [7-13].* Correspondence: clair.mills@northlanddhb.org.nz
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reproduction in any medium, provided the origHealth inequities between indigenous Māori children
and non-Māori children in New Zealand remain signifi-
cant and persistent, particularly in relation to infectious
diseases, injury and infant and child mortality rates. For
example, Māori infants have rates of Sudden Unexpected
Death in Infancy (SUDI) over six times non-Māori
infants, are nearly three times more likely than non-
Māori to be hospitalised with bronchiolitis, and as chil-
dren have much higher rates of rheumatic fever and
bronchiectasis than non-Māori [3]. This scoping study
aimed to carry out a preliminary analysis of the cost of
health inequities between Māori and non-Māori children
in New Zealand.Methods
Kaupapa Māori methodology
This study is positioned within a Kaupapa Māori theor-
etical framework, a research approach that is criticallyd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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the marginalisation of indigenous peoples [14,15].
Kaupapa Māori methodology is driven by a Māori world
view and recognises the complexity of Māori historical
and contemporary realities. Understanding the current
health inequities experienced by Māori children and
young people requires an understanding of New
Zealand’s colonial history and the erosion of the social,
economic, political, and cultural base for Māori whānau
and iwi (families and kinship groups/tribes), from the
early 1800s onwards [3]. Kaupapa Māori methodology
privileges the indigenous Māori “voice”, validating and
legitimising Māori language, knowledge, culture and
values. It acknowledges and challenges the power dy-
namics that have created and maintain the unequal pos-
ition of Māori in New Zealand society, including the
role played by the socio-economic determinants of
health and the health system in limiting Māori health
outcomes [15].
In this study, quantitative epidemiological and eco-
nomic costing methods are used as tools, with questions
and findings developed and interpreted within a
Kaupapa Māori framework. The analysis reflects this
understanding by placing Māori children as the group
“at the centre” of this analysis rather than at the
margins.
Measures of child health inequity
The focus of this study is on inequities; therefore our
analysis is based on the deaths and hospitalisations that
are categorised as “potentially avoidable”, using New
Zealand Ministry of Health and District Health Board
(DHB) definitions [16-18]. This includes illness and in-
jury preventable through primary care intervention, in-
jury prevention or health promotion approaches. The
International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision, Australian
Modification (ICD-10-AM) diagnostic coding was used
for all admissions and deaths [19]. We assigned children
to Māori and non-Māori groups using Ministry of
Health protocols for prioritised ethnicity; that is, anyone
who identified as Māori, either alone or as one of mul-
tiple ethnic groups, was included in the Māori group
[20].
Datasets were obtained with permission from Statistics
New Zealand (SNZ) and the New Zealand Health Informa-
tion Service (NZHIS). We calculated the number and crude
rates of death from avoidable causes by ethnicity and age
group (age groups: 0–1 month, 1 month< 1year, 1-
< 5years, 5-< 15years) using SNZ death registration data
coded by NZHIS for 2003–2007. Live births from 2003–
2007 (SNZ birth registration data, excluding stillbirths,
coded by NZHIS) were used as the denominator to esti-
mate neonatal (<28days) and post-neonatal (defined as28days-< 1year) infant mortality and hospital admission
rates [unpublished datasets, SNZ and NZHIS]. For mortal-
ity rates in children over one year, population estimates
from New Zealand Census data were used to estimate
Māori and non-Māori rates [21,22].
Avoidable deaths were assigned by their primary ICD-
10AM code into ICD-10AM chapter groupings. The
number of avoidable deaths that would have occurred
had Māori had the same rate as non-Māori in each age
band was computed, with the difference between the ac-
tual number of deaths and the estimated deaths repre-
senting excess avoidable deaths. The resulting number
of years of life lost (YLL) by Māori children was com-
puted, assuming that all would have lived to the 2005 life
expectancy of their non-Māori same-sex counterparts
[23].
We obtained the number and crude rates of hospitali-
sations from potentially avoidable causes by ethnicity
and age group (Māori, non-Māori; age groups: 0-
< 1year, 1-< 5years, 5-< 15years) from hospitalisation
data (National Minimum Dataset, NZHIS) for the same
period, 2003–2007. The number of avoidable hospitalisa-
tions that would have occurred if Māori had the same
rate as non-Māori in each age band and diagnostic
grouping (ICD-10AM chapter) was computed, with the
difference between the actual number of hospitalisations
and the estimated hospitalisations representing excess
avoidable hospitalisations.
We assumed that injuries were as avoidable for Māori
as for non-Māori children, thus that any difference in in-
jury rates was inequitable, and that the incidence of in-
jury and primary care-responsive illness was at least as
high in Māori as non-Māori children [24,25]. Primary
care utilisation rates were estimated based on Primary
Health Organisation (PHO) service utilisation data for
visits for enrolled populations during routine hours for
the years 2007–8 [unpublished datasets, used with per-
mission of District Health Boards NZ]. Total utilisation
rates were compared, as the quality of diagnostic coding
in primary care precluded sub-group analysis. The num-
ber and rate of general practice (first point of contact
personal and family primary medical care services) and
primary care nursing visits were calculated for Māori
and non-Māori children by age group (0-< 5years, 5-
< 15years). The number of consultations that would
have occurred if Māori had the same rate as non-Māori
were computed by age group, with the difference be-
tween the actual number of visits and the estimated
number representing “excess” or “under-utilisation.”
Similar methods were applied to Accident Compensa-
tion Corporation (ACC) injury claims, pharmaceutical
and laboratory claims and outpatient datasets, estimating
excess or under-utilisation for total claims/visits. Labora-
tory and pharmaceutical data have only recently been
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gated by ethnicity), so we used the most recent years
available (2006–8), as NZHIS advised NHI linking was
then over 95% complete [personal communication,
NZHIS].Economic costing methods
We reviewed the available literature on costing health
inequities and assessed relevant economic methods. This
review suggests that there are significant unresolved
challenges in valuing child health and disability that con-
tinue to be debated in the literature. Many of the
assumptions of neoclassical economics do not hold for
children and are indifferent to concepts of equity [26-
32]. Monetising the value of a child’s life and discounting
future benefits (used by economists to reflect the as-
sumption that future benefits are less valued than bene-
fits enjoyed in the present) remain contentious in the
health sector and do not fit easily within a kaupapa
Māori framework. Re-interpreting cost benefit analysis
theory within such a framework is an interesting direc-
tion for future kaupapa Māori research. In the absence
of this, we chose to use “cost of illness” methods [33-37]
in this preliminary study, with a limited prevalence-
based perspective. This restricts estimates to a range of
publicly funded health sector costs, the cost of prema-
ture mortality, “out of pocket” care-giver expenditure on
primary care, and loss of days of work for care-givers,
due to excess avoidable hospital admissions of their chil-
dren. We estimated an annual cost based on the total
costs of the “inequity excess” for the period 2003–7.Costs of health care
Costing data for hospital admissions was based on the
National Pricing Project (NPP) 2008–9 dataset [unpub-
lished data, Ministry of Health]. The direct hospital cost
savings (or extra costs) if Māori children had avoidable
admission rates equal to non-Māori children was com-
puted using the weighted median Diagnostic Related
Group (DRG) costs for each ICD-10AM category and
age group. ACC injury claims cost data, Pharmaceutical
Management Agency of New Zealand (PHARMAC)
pharmaceutical claims and NZHIS laboratory services
claims for 2007–8 were used to cost those services.
Māori:non-Māori differences in the use of ACC, labora-
tory and pharmaceutical services were costed using the
weighted median costs of non-Māori claims in each age
group. Paediatric outpatient visits (including mental
health) were assigned the Weighted Inlier Equivalent
Separations (WIES) inter-district flow cost (2008–9) for
a paediatric medical outpatient visit of $343.23.
We estimated the difference in primary care costs
using the “notional” Ministry of Health general medicalsubsidy amount per visit and assumed a nursing visit
total cost of $30 [38,39].“Out of pocket” costs in primary care and costs of
parental days of work lost
For primary care, we conservatively assumed the median
“out of pocket” expenditure for children under six in
2007–2008 as zero, that children aged six and over were
all subsidised $15 for general practitioner (family doctor)
and nursing visits, and that caregivers “out of pocket”
payments represented the difference between that and
the notional visit cost [38-40]. A conservative estimate
of the cost of work days lost (measured as wages) was
based on loss of two days work (the weighted median
length of stay in this study) for each “excess” admission,
for one parent at the 2007–2008 gross median wage
($NZ35,000) [41].Costs of years of life lost
We used non-Māori male and female life expectancy
from SNZ Life Tables 2005–7 [23] to derive the excess
avoidable “Years of Life Lost” (YLL). Various discounting
rates were then applied to test the impact of different
time preferences, using discount rates applied in recent
New Zealand cost of illness studies [33-36].
Two methods were used to assign costs to YLL. Firstly,
we assumed a “base case” scenario of a mean life expect-
ancy at birth of 78 years, a 3% discount rate, and esti-
mated the total cost of YLL by dividing the “base case”
Value of a Statistical Life (VoSL) of $NZ3.352million
[35,36] by the Statistical Lives lost (“Method 1”). We
assumed that the VoSL included lost production costs.
We also computed costs applying standard economic
methods used by O’Dea & Tucker and others [34,35]
(“Method 2”) to allow comparability with other New
Zealand cost of illness studies. Using this methodology,
the VoSL has the same value for both genders, but given
life expectancy is gender-dependent, the value of a “year
of life lost” varies depending on age and gender of the
avoidable deaths. The annualised value of the VoSL is
calculated using the equation VosL = Sum [VoSLY/
(1 + d)L], where d is the discount rate and L the life ex-
pectancy. Therefore the VoSLY=VoSL*d/[1-(1 + d)−L],
where d = the discount rate, and L is life expectancy.Results
Table 1 summarises the results for avoidable hospitalisa-
tions and healthcare costs of differential utilisation by
Māori and non-Māori children. The estimate of the
health sector costs of inequity in childhood illness and
injuries is a cost saving to the health sector of
$24,737,408 per annum.
Table 1 Māori: non-Māori Rate Ratios and Estimates of the Cost to the Health Sector of Inequity in Illness and Injury ($NZ)
Māori: non-Māori Rate Ratio If Māori rates equaled non-Māori rates: Cost[-savings]/year (0% discount rate)
Avoidable hospital admissions (2003–7) 1.27 (95% CI 1.26–1.28) 3075 fewer Māori admissions/year $ 5,671,057
Outpatient consultations (2006–2008) 0.864 (95% CI 0.862–0.867) 23,373 more consultations/year [−]$ 8,022,315
Mental health consultations (20007–8) 0.719 (95% CI 0.714–0.723) 5740 more consultations/year [−]$ 1,970,140
ACC claims (2003–7) 0.680 (95% CI 0.678–0.683) 26,442 more claims/year [−]$ 1,499,765
Primary care (2007–2008) 0.919 (95%CI 0.916–0.921) GP visits 40,041 more GP consultations/year [−]$ 1,079,906
1.677 (95%CI 1.665–1.689) nursing visits 17,194 fewer nursing consultations $ 400,803
Pharmaceutical claims (2007–8) 0.849 198,108 more claims/year [−]$ 10,447,348
Laboratory claims (2006–8) 0.454 (95%CI 0.452–0.455) 101,922 more claims/year [−]$ 7,789, 795
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There were a total of 871,094 hospital admissions for
children <15 years in the period 2003–2007. The crude
rate ratio for total Māori:non-Māori admissions was 0.98
(95% CI 0.975–0.984). 36% of hospitalisations of children
in this age group were classified as “potentially avoid-
able”. Māori:non-Māori rate ratios for potentially avoid-
able hospitalisation rates were significantly greater than
one in all age groups. Respiratory diseases made the
greatest contribution to the “excess”, with diseases of the
ear, digestive system and skin, and injuries also being
important. In children aged 5–15years the highest rate
ratio was for circulatory diseases (including rheumatic
heart disease), where the Māori:non-Māori rate ratio
was 3.33 (95% CI 2.93–3.79). Overall, summing the “ex-
cess” avoidable hospitalisations, there were a total of
15,376 “excess” Māori avoidable admissions during
2003–7 or 3,075 each year.
Inequity in hospital general outpatient and mental health
outpatient consultations (2006–2008)
Hospital outpatient utilisation rates for Māori children
were consistently lower than for non-Māori children for
all age groups in the period July 2006-December 2008
(Table 1). The overall Māori:non-Māori rate ratio was
0.864 (95% CI 0.862–0.867). If Māori children had the
same outpatient consultation rate as non-Māori there
would have been 23,373 more consultations by Māori
children annually. Māori children were nearly 30% less
likely than non-Māori to attend outpatient mental health
services. If Māori had the same consultation rate as
non-Māori there would have been 5740 more consulta-
tions by Māori children per year in mental health
services.
Inequity in Accident Compensation Corporation (ACC)
accident and injury consultations (2003–2007)
There were 291,502 Māori and 1,322,560 non-Māori
ACC claims for children< 15years during the 2003–
2007 period. Māori rates were significantly lower than
non-Māori, with an overall rate ratio of 0.680 (95% CI
0.678–0.683). There were 26,442 fewer claims per year
by Māori children in the period than if claims had been
made at the non-Māori rate.
Inequity in primary care (2007–2008)
A mean number of 353,734 Māori and 1,374,972 non-
Māori children were enrolled in Primary Health Organi-
sations (PHOs) during 2007–8; fewer in total than the
SNZ population estimates for the same period, and a
significantly lower proportion of Māori children than in
official population estimates. If Māori children had con-
sulted GPs at the same rate as non-Māori, there would
have been 40,041 more GP consultations annually.Nursing consultations showed the inverse; although total
nursing consultations were much fewer than GP consul-
tations, Māori utilisation rates were 1.68 times greater
than non-Māori, resulting in 17,194 consultations more
than expected if Māori utilisation had been equivalent to
the non-Māori rate.
Inequity in pharmaceutical claims (2007–2008)
There were over 7.9 million pharmaceutical claims for
children <15 years during 2007–8; only 21.7% of these
were for Māori <15years. Māori rates of claims were sig-
nificantly lower than non-Māori, representing an
“under-utilisation” of 198,108 claims per year.
Inequity in laboratory utilisation (2007–2008)
In 2007–8 there were 1.28 million laboratory claims for
children <15years; 12.9% of these were recorded as
being for Māori children. The overall Māori:non-Māori
rate ratio was 0.454 (95% CI 0.452–0.455); rate ratios in
children <1years were even lower. There would have
been 101,922 more claims by Māori children each year if
Māori had the same rate of laboratory use as non-Māori.
Inequity in avoidable mortality
In the period 2003–7 there were 299,421 live births and
2,345 deaths in children aged 0-< 15yrs. 85% of these
deaths were “potentially avoidable”. If Māori avoidable mor-
tality rates had equalled non-Māori rates for each age group
in the period, there would have been 333 fewer Māori
deaths (nearly 67 deaths per year); 56% of these would be
in the 28 day- <1year age group (Table 2).
Māori avoidable mortality rates were significantly
higher than non-Māori in all age groups except for the
first month of life. The biggest contributor to mortality
in this age group was deaths related to perinatal condi-
tions (mainly resulting from prematurity), where Māori
infant mortality rates were non-significantly higher than
non-Māori.
In the age group 28days-<1year, 41.5% of the avoid-
able deaths were assigned “Sudden Unexpected Death in
Infancy” (SUDI) codes. SUDI rates were significantly
higher for Māori and especially Māori males in this age
group; respiratory diseases (J00-99 codes) were the other
main contributor to Māori infant deaths under one year.
There were significantly higher rates in Māori for “exter-
nal causes” (accident, injury and assault codes V01-Y98) in
all age groups, with the highest rates and rate ratios seen in
infants 28 days - <1year. In girls 1–5years, the Māori:non-
Māori rate ratio for injury/external causes was 3.35 (95% CI
2.00–5.62), and this accounted for nearly all the excess
deaths. In 5–15year-old girls, nearly two thirds of the “ex-
cess” mortality was injury-related. In 5–15year-old males,
injury/external causes again contributed to the majority of
“excess” deaths, although the highest Māori:non-Māori rate





















0-<28days 260 300.65 593 278.48 1.08 (0.93–1.25) 240.8 19.17
28days- <1 year 302 349.22 279 131.02 2.67 (2.27–3.14) 113.3 188.69
1 year-<5years 98 33.62 139 16.43 2.05 (1.58–2.65) 47.9 50.09
5years-<15yrs 132 18.53 184 7.98 2.32 (1.86–2.90) 56.8 75.17
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tious and parasitic diseases, and endocrine, nutritional and
metabolic diseases).
Estimation of years of life lost from premature mortality
The years of life lost (YLL) to excess avoidable mortality in
each age/sex group was computed, based on the difference
between the midpoint of age of death in each age group
and the non-Māori life expectancy for their same sex coun-
terpart. The total value was 5210 life years lost per year.
We examined the data using a range of discount values,
based on those used in recent NZ cost of illness studies
[33-37,42-44]. Applying a discount rate of 3% reduces the
life years lost to 38% of their present value; if it is increased
to 8%, it is only 16% of present value (831 life years)
(Table 3).
Cost of years of life lost
The Method 1 “base case” scenario assumes a mean life ex-
pectancy at birth of 78 years, YLL discounted at 3%, and
uses the New Zealand Ministry of Transport VoSL at June
2008 prices ($3,352,000) [36,42]. The YLL at 3% discount-
ing are equivalent to the value of 25.7 “Statistical Lives” an-
nually, computing to a cost of $NZ86.18 million annually at
present value.
Method 2 results in similar values to Method 1 at zero
discounting ($NZ223.3million per year), but as the
VoSLY increases in Method 2 with increases in the dis-
count rate, at 3% this computes to $NZ224 million per
annum.
Costs to society and family
The cost of work days lost by caregivers is based on the
median length of stay for avoidable hospital admissions.
This computes to $269 for each of the 3075 annualTable 3 Years of Life Lost (YLL) from Avoidable Māori
Child Deaths by Age Group and Gender, at Varying
Discount Rates
Years of Life Lost (YLL) 0% 3%“Base Case” 5% 8%
0–1yr female 7279 2680 1726 1095
1–5yr female 1825 689 446 283
5–15yr female 2926 1182 776 497
Total Female 12030 4551 2948 1875
0–1yr male 9480 3626 2353 1498
1–5yr male 2091 820 535 341
5–15yr male 2450 1029 683 439
Total Male 14021 5475 3571 2278
Total 2003–7 26051 10026 6518 4153
Annual YLL 5210 2005 1304 831
Equivalent “Statistical Lives”* 66.8 25.7 16.7 10.6
*Assumes life expectancy of 78 years.“excess” avoidable admissions, a total cost of $827,175
per year. Māori caregivers “out of pocket” payments for
primary care were estimated to be $245,523 less than
expected, primarily due to lower GP consultation rates
for tamariki Māori.
Table 4 shows the total annualised cost estimate for
each method.
Sensitivity analysis
We examined the impact of different discount rates,
using both methods. Method 1 results in a rapid de-
crease in present value as the discount rate increases.
However using O’Dea & Tucker’s method there is little
variability in the total value at differing discount rates
(Table 5).
We also varied the “value of a statistical life year”
(using values derived from previous studies [34-37]);
predictably this has a significant impact on the final re-
sult, as the cost of “excess” avoidable mortality is a large
proportion of the total costs (Table 6). The final range of
estimates shows the total cost is highly sensitive to the
method used, and the discount rate and VoSL applied.
Discussion
There have been many calls to reduce inequities in the
health of New Zealand children [3,45-47]. In addition to
social justice and ethical rationale for health equity, the
economic costs that we bear through continued health
inequities are important to consider. Assigning a monet-
ary value to life or health remains antithetical to some.
However, economic evaluation is commonly accepted as
a consideration in decision-making, for example in allo-
cation of government spending, and we believe this
scoping study is an important initial step in developing
more appropriate methods for examining the true costs
of inequity.
While a preliminary attempt is described here, the cost-
ings that result can be considered highly conservative andTable 4 Comparison of Annualised Costs of the “Base
Case” Scenario at 3% Discount Rate using Alternative
Methods
Cost category Annual value ($NZ)
Health sector costs −$24,737,408
Loss of wages $827,175
Out of Pocket Costs (Primary Care) −$245,523
Sub-total −$24,155,756
Method 1: Years of Life Lost $86,181,425




Table 5 Cost of Years of Life Lost (YLL) by Age group and Gender at Varying Discount Rates (Method 2) ($NZ)
Cost of YLL 0% “Base case” 3% 5% 8%
0–1yr female $294,130,013 $294,947,777 $294,391,755 $294,180,462
1–5yr female $76,163,022 $76,394,291 $76,240,799 $76,179,257
5–15yr female $133,695,626 $134,198,138 $133,878,164 $133,730,682
0–1yr male $402,528,431 $403,786,759 $402,944,243 $402,597,057
1–5yr male $91,790,026 $92,102,235 $91,897,812 $91,809,104
5–15yr male $118,240,841 $118,747,980 $118,437,538 $118,282,829
Total $1,116,547,960 $1,120,177,180 $1,117,790,309 $1,116,779,391
Annual $223,309,592 $224,035,436 $223,558,062 $223,355,878
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have not assumed that all “avoidable” deaths and hospitali-
sations can be eliminated, but used a conservative counter-
factual, estimating the number of potentially avoidable
deaths/admissions/consultations that would have occurred
if Māori children had the same rate as non-Māori in each
age group.
Secondly, if non-Māori, non-Pacific children (i.e. pre-
dominantly New Zealand European) are used as the
comparator group, greater inequities become apparent,
given the high rates of illness and mortality experienced
by Pacific children in New Zealand. 99 fewer deaths per
year (nearly 77 of them Māori) and just under 10,000
hospital admissions would be prevented if Māori and
Pacific children had the same rates of death and illness
as non-Māori, non-Pacific children [data not shown].
In addition, we have not attempted to cost many of
the childhood “diseases of inequity” such as rheumatic
fever and bronchiectasis, which have lifelong impacts.
We acknowledge that many of the significant social and
intangible costs to children and families are not cap-
tured, including grief and suffering, missed educational
opportunities, and employment and productivity losses
for family, caregivers and for the child into the future.
The key findings, however, are important. Firstly, these
estimates give an indication of the significant societal
cost of inequities in health. As might be expected from
similar economic analyses and other cost of illness stud-
ies, the human cost of the inequity in premature mortal-
ity is the greatest cost to society, rather than direct
health system costs.
Secondly, health sector expenditure appears skewed
towards non-Māori children. Our analysis suggests that
it costs the health sector less to admit acutely sick Māori
children, than to prevent severe illness through ensuring
equitable primary care access or effective population-
based interventions. Therefore a Ministry of Health con-
cerned only with containing health sector spending has
no incentive to reduce inequities in primary care access.
Lower utilisation of primary care and higher rates of
potentially avoidable hospitalisations for Māori children
are not new findings, despite persisting evidence ofunmet need for primary care-amenable conditions
[3,24,47]. Although primary care utilisation for all ethnic
groups has increased since the introduction of the NZ
Primary Health Care Strategy (2001) with additional
funding to PHOs to improve financial access, the largest
increase in utilisation has been by less deprived popula-
tions, where Māori are under-represented compared
with non-Māori [48]. The reasons for poorer access to
primary care are likely to be multi-factorial, including
socio-economic factors. As primary care utilisation
drives access to most other health services, including
specialist outpatient services, addressing access barriers
and attaining equitable utilisation of primary care ser-
vices by Māori children has the potential to reduce the
unacceptable disparities in avoidable hospitalisations and
mortality seen here, and produce economic benefits that
offset the costs of service delivery. Further intervention
research in this area is crucial to understanding and
addressing this inequity.
There are evident limitations in this study, and some
unresolved challenges. Kaupapa Māori is a research
methodology that utilises various research tools (in this
case economic methods) to examine and contextualise
Māori lived realities, to inform Māori development. Part
of the spectrum of a Kaupapa Māori approach parallels
Critical Theory and seeks to reveal inequity and chal-
lenge injustice. A major concern therefore in valuing
child health and inequities relates to the values and
assumptions of current economic approaches, and the
appropriateness of the costing methods derived from
these. The theoretical basis of “welfare economics”,
which is the conventional neo-classical economic ap-
proach to social goods, is essentially utilitarian
[27,36,49,50]. This assumes that the welfare output is
maximised and is a function of individual preferences,
where everyone is thought to maximise their own “util-
ity” (i.e. the benefits they gain from their preferred
choice of “goods”). This could be seen as antithetical to
Māori values and concepts of reciprocity. It also presup-
poses that individuals are fully informed to make deci-
sions in a free market, which is not an assumption easily
applied to child health.
Table 6 Value of YLL from Childhood Inequities, varying VoSL Values and Discount Rates ($NZ)
VoSL value
(June 2008 prices)
0% “Base case” 3% 5% 8%
Method 1 Method 2 Method 1 Method 2 Method 1 Method 2 Method 1 Method 2
$2.212m (Fire Safety, 2007 [43]) $147,797,553 $147,384,352 $56,879,748 $147,863,409 $36,981,626 $147,548,342 $23,563,447 $147,414,901
$3.352m (Transport 1991 [42]) $223,935,654 $223,309,592 $86,181,425 $224,035,436 $56,032,759 $223,558,062 $35,702,187 $223,355,878
$5.676m (Transport 1998 [36]) $379,192,367 $378,132,251 $145,931,824 $379,361,329 $94,880,802 $378,552,987 $60,454,853 $378,210,627
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ics approach includes its indifference to the distribution
of “utilities” (in this case, health states) across individuals
and thus to concepts of equity, including intergenera-
tional equity, which is important to consider in valuing
child health [26,28,30]. Despite these limitations, it
remains the conceptual basis for economic evaluation in
the health sector.
Cost of illness methodology is descriptive, valuing in
dollar terms the costs of a particular health problem,
which then enables the economic burden of the problem
to be estimated. Cost of illness studies are not considered
full economic evaluations because they do not assess cost
effectiveness or the cost-benefits of comparable interven-
tions, and are critiqued by many welfare economists as
not being sufficiently grounded in welfare economics the-
ory. Other critique relates to the use of the human capital
approach to evaluate the value of life. Despite these limita-
tions, they can call attention to the importance of specific
health issues, as demonstrated here [37,51].
A further area of debate in economic studies is how to
value the loss of a life, as well as non-fatal outcomes
such as the loss of function and lifetime sequelae of ill-
ness, especially for children [24,32,52-54]. There is some
evidence that people may value a young person’s life
more than an older person’s one [54,55]. Assigning a
monetary value to life and health remains controversial,
and there is considerable variation in “value of life”
values obtained in empirical “willingness-to-pay” studies.
We have used what is now regarded as a very conserva-
tive VoSL figure [35,56].
Discounting is another particular challenge in valuing
child health. Discounting implies we value something
more if we have utility from it today than in the future.
For example, preventing the death of one infant achieves
a gain of over 80 life-years, but this amounts to only 12
life years discounted at 8% (Treasury’s default rate in
New Zealand [57,58]). There is considerable controversy
about applying “market” discount rates to health, and
ongoing debate about the assumptions underlying differ-
ent discount rates [36,58]. Some argue that the discount
rate should vary over time, rather than be applied at a
constant rate, and it is not clear how sensible time pre-
ferences can really be for events over fifty years into the
future [59]. It is unlikely that we would prefer to denycrucial preventive interventions for children, simply
because the potential costs in terms of ill health would
only be borne far into the future.
Data quality is another area of potential uncertainty.
Although ethnicity coding in New Zealand has become
more complete and accurate over the last decade, mis-
classification and under-counting of Māori is still
reported across the health sector [60]. In our data, there
does not appear to be any net undercount of Māori in
birth and mortality datasets [61]. Hospital numerator
undercounting is estimated to be relatively small for
young children, so we did not adjust for this [61]. For
the laboratory, pharmaceutical, outpatient and ACC
datasets there were small numbers of missing ethnicity
values (<3%). In primary care, undercounting and mis-
classification of Māori persists [60,62,63], and is borne
out in this study when enrolment data is compared with
population estimates. Undercounting in the Census is
described, especially of Māori and youth [64]; we used
the Statistics New Zealand population estimates that are
based on adjusted Census data, using post-census enu-
merator surveys to estimate the extent of undercount.
Overall, ethnicity misclassification and undercounting
of Māori is unlikely to have significantly altered the
overall findings.
Conclusions
Our study shows that in addition to being preventable,
unnecessary and a breach of child rights, inequities in
child health result in significant costs to our society.
Effective interventions to address health inequities are
available, although further investment in understanding
and evaluating these is urgently needed. Improved
access to primary care [65-67], better housing [68,69],
lowering child poverty rates [46,70] and the provision of
quality early childhood education and childcare [71]
have been shown to impact positively on both child
health and longer-term health outcomes. As inequities
in adult health are closely associated with inequities in
childhood health [46,72], strategies to reduce inequities
in child health should be given high priority given the
longer term social and economic benefits to be gained.
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